BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of $14.19 billion as of December 5, 2025. Its market cap has increased by 233.14% in one year.

Market Cap

14.19B

Enterprise Value

15.40B

1-Year Change

233.14%

Ranking

#740

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $14.19B, an increase of 327.47%. That is a compound annual growth rate of 25.28%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	14.19B	173.65%
Dec 31, 2024	5.19B	-26.16%
Dec 29, 2023	7.02B	516.56%
Dec 30, 2022	1.14B	-53.61%
Dec 31, 2021	2.46B	-71.83%
Dec 31, 2020	8.72B	101.23%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings